TEMP/E-1/36762/2018-CHE

A proprietary bioactive compound derived from Punarnava, designed to modulate immune responses in conditions characterized by immune dysregulation, inflammation, and chronic disease states.

TEMP/E-1/36773/2018-CHE

This invention describes a standardized immunomodulatory extract from Piper nigrum, developed to influence immune balance and support systemic inflammatory regulation.

TEMP/E-1/36766/2018-CHE

A novel compound isolated from Karavella with potential applications in immune modulation, metabolic regulation, and inflammatory control.

TEMP/E-1/36763/2018-CHE

A proprietary Guduchi-derived compound developed for restoring immune equilibrium in chronic inflammatory and immune-compromised conditions.

TEMP/E-1/36867/2018-CHE

An immunologically active extract from Inula racemosa, formulated to support immune regulation and resilience in chronic disease states.

TEMP/E-1/36767/2018-CHE

This patent covers a bioactive compound from Sonti, aimed at modulating immune responses and reducing pathological immune overactivity.

TEMP/E-1/36771/2018-CHE

A standardized immunomodulatory formulation derived from Vacha, developed to influence neuro-immune signaling and systemic immune balance.

TEMP/E-1/36759/2018-CHE

A novel compound sourced from Udumbara with applications in immune modulation and regenerative support.

TEMP/E-1/36768/2018-CHE

This invention describes a Haridra-based compound optimized for immunomodulatory activity and inflammatory regulation.

TEMP/E-1/36758/2018-CHE

A bioactive extract from Shobanjan designed to support immune homeostasis and systemic resilience.

TEMP/E-1/36765/2018-CHE

A proprietary Haritaki-derived compound developed to influence immune regulation and chronic inflammatory pathways.

TEMP/E-1/36756/2018-CHE

An immunomodulatory formulation derived from Mundi, focused on restoring immune balance in complex disease conditions.

TEMP/E-1/36502/2018-CHE

A multi-component polyherbal formulation developed to address malignant and pre-malignant conditions through systemic immune and metabolic regulation.

TEMP/E-1/36354/2018-CHE

A digital clinical assistant platform that utilizes organ-specific electrical activity patterns to support diagnostic and decision-making processes.

TEMP/E-1/36368/2018-CHE

A novel diagnostic methodology based on capturing and interpreting registered action potentials to assess organ function and disease states.

TEMP/E-1/36996/2018-CHE

A broad-spectrum polyherbal composition designed to restore immune balance across inflammatory, autoimmune, and chronic disease conditions.

TEMP/E-1/36539/2018-CHE

A proprietary compound developed to re-establish healthy interactions between gut microbiota and the immune system.

TEMP/E-1/36772/2018-CHE

A novel Talispatra-derived compound with applications in immune regulation and inflammatory control.

TEMP/E-1/36010/2018-CHE

An invention describing a Corilagen-derived compound intended for supportive intervention in oncological conditions.

TEMP/E-1/36774/2018-CHE

A therapeutic methodology designed to manage and mitigate post-progression effects associated with multiple sclerosis.

TEMP/E-1/36367/2018-CHE

A hybrid diagnostic device integrating bioelectrical organ signals with biochemical parameters for enhanced clinical assessment.

TEMP/E-1/38309/2018-CHE

A regenerative therapeutic approach aimed at supporting neural recovery following hypoxic brain injury.

TEMP/E-1/36031/2018-CHE

A proprietary polyherbal-mineral formulation designed to regulate gastrointestinal function and systemic metabolic balance.

TEMP/E-1/36485/2018-CHE

A standardized Pippali-derived compound developed for immune modulation and systemic inflammatory regulation.

TEMP/E-1/36761/2018-CHE

A novel NagarMustak-based formulation aimed at restoring immune homeostasis.

TEMP/E-1/36008/2018-CHE

A novel therapeutic application of the plant hormone 24-Epibrassinolide in human health and disease modulation.

TEMP/E-1/36864/2018-CHE

A proprietary extract developed for the management of allergic and hypersensitivity responses.

TEMP/E-1/36863/2018-CHE

A formulation based on 6-Hydroxy Luteolin designed to address allergic and immune-mediated conditions.

TEMP/E-1/36011/2018-CHE

An Ellagic acid-derived compound developed for adjunctive cancer therapy and immune-oncology applications.

—

A novel nano-engineered gold particle designed for biomedical and therapeutic applications.

TEMP/E-1/36038/2018-CHE

A multi-component formulation aimed at influencing epigenetic regulation in oncological conditions.

TEMP/E-1/36512/2018-CHE

A polyherbal therapeutic approach targeting endocrine-related tumors and adenomatous growths.

TEMP/E-1/36119/2018-CHE

A proprietary formulation designed to manage bleeding hemorrhoids through tissue and vascular regulation.

TEMP/E-1/36877/2018-CHE

A novel processing methodology enhancing the antitumor potential of Vinca rosea-derived compounds.

TEMP/E-1/36729/2018-CHE

A therapeutic formulation developed to support platelet regulation in idiopathic thrombocytopenic purpura.

TEMP/E-1/36006/2018-CHE

A proprietary polyherbal compound designed for migraine regulation and neurovascular stability.

TEMP/E-1/36869/2018-CHE

An enhanced formulation of Jasminum augustifolium aimed at improving antitumor activity.

—

A novel manufacturing and processing methodology for producing a standardized phthalazine-based derivative.

TEMP/E-1/36769/2018-CHE

A proprietary Arkapatra-derived compound developed for immune system modulation.

—

A novel compound identified as a PARP-inhibitory agent with potential applications in oncology and DNA-repair–related disorders.